{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T18:23:08Z","timestamp":1791397388240,"version":"4.3.3"},"reference-count":113,"publisher":"BMJ","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Clin Pathol"],"accepted":{"date-parts":[[2008,7,29]]},"published-print":{"date-parts":[[2008,11]]},"abstract":"<jats:p>Peripheral T cell lymphomas (PTCL) account for about 12% of lymphoid tumours worldwide. Almost half show such morphological and molecular variability as to hamper any further classification, and to justify their inclusion in a waste-basket category termed \u201cnot otherwise specified (NOS)\u201d. The latter term is used for neoplasms with aggressive presentation, poor response to therapy and dismal prognosis. In contrast to B cell lymphomas, PTCL have been the subject of only a limited number of studies to elucidate their pathobiology and identify novel pharmacological approaches. Herewith, the authors revise the most recent contributions on the subject based on the experience they have gained in the extensive application of microarray technologies. PTCL\/NOS are characterised by erratic expression of T cell associated antigens, including CD4 and CD52, which have recently been proposed as targets for ad hoc immunotherapies. PTCL\/NOS also show variable Ki-67 marking, with rates &gt;80% heralding a worse prognosis. Gene expression profiling studies have revealed that PTCL\/NOS derive from activated T lymphocytes, more often of the CD4+ type, and bear a signature composed of 155 genes and related products that play a pivotal role in cell signalling transduction, proliferation, apoptosis and matrix remodelling. This observation seems to pave the way for the use of innovative drugs such as tyrosine kinase and histone deacetylase inhibitors whose efficacy has been proven in PTCL primary cell cultures. Gene expression profiling also allows better distinction of PTCL\/NOS from angioimmunoblastic T cell lymphoma, the latter being characterised by follicular T helper lymphocyte derivation and CXCL13, PD1 and vascular endothelial growth factor expression.<\/jats:p>","DOI":"10.1136\/jcp.2008.055335","type":"journal-article","created":{"date-parts":[[2008,8,28]],"date-time":"2008-08-28T20:26:26Z","timestamp":1219955186000},"page":"1160-1167","source":"Crossref","is-referenced-by-count":60,"title":["Peripheral T cell lymphoma, not otherwise specified: the stuff of genes, dreams and therapies"],"prefix":"10.1136","volume":"61","author":[{"given":"C","family":"Agostinelli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P P","family":"Piccaluga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Went","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Gazzola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Righi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Sista","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Campidelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P L","family":"Zinzani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"Falini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S A","family":"Pileri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2008,8,28]]},"reference":[{"key":"2025121403104389000_61.11.1160.1","unstructured":"Jaffe E S Harris N L Stein H Vardiman J W , eds. Pathology and genetics: tumours of haematopoietic and lymphoid tissues (World Health Organization Classification of Tumours). Lyon: IARC Press, 2001."},{"key":"2025121403104389000_61.11.1160.2","first-page":"23","article-title":"Understanding the group of peripheral T-cell lymphomas, unspecified.","volume":"4","author":"Zucca","year":"2005","journal-title":"Curr Hematol Rep"},{"key":"2025121403104389000_61.11.1160.3","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1182\/blood.V84.5.1361.1361","article-title":"A revised European\u2013American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group.","volume":"84","author":"Harris","year":"1994","journal-title":"Blood"},{"key":"2025121403104389000_61.11.1160.4","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s11864-004-0020-8","article-title":"Treatment of T-cell non-Hodgkin\u2019s lymphoma.","volume":"5","author":"Evens","year":"2004","journal-title":"Curr Treat Options Oncol"},{"key":"2025121403104389000_61.11.1160.5","doi-asserted-by":"publisher","DOI":"10.1023\/A:1008418727472"},{"key":"2025121403104389000_61.11.1160.6","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1097\/00000478-200103000-00015","article-title":"Peripheral T-cell lymphoma with follicular involvement and a CD4+\/bcl-6+ phenotype.","volume":"25","author":"de Leval","year":"2001","journal-title":"Am J Surg Pathol"},{"key":"2025121403104389000_61.11.1160.7","doi-asserted-by":"publisher","DOI":"10.1097\/00000478-200001000-00014"},{"key":"2025121403104389000_61.11.1160.8","doi-asserted-by":"publisher","DOI":"10.1007\/s00428-004-1077-2"},{"key":"2025121403104389000_61.11.1160.9","first-page":"76","article-title":"Prognostic significance of T-cell phenotype in aggressive non-Hodgkin\u2019s lymphomas. Groupe d\u2019Etudes des Lymphomes de l\u2019Adulte (GELA).","volume":"92","author":"Gisselbrecht","year":"1998","journal-title":"Blood"},{"key":"2025121403104389000_61.11.1160.10","doi-asserted-by":"publisher","DOI":"10.1023\/A:1008205619617"},{"key":"2025121403104389000_61.11.1160.11","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdf033"},{"key":"2025121403104389000_61.11.1160.12","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)63742-X"},{"key":"2025121403104389000_61.11.1160.13","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-09-3801"},{"key":"2025121403104389000_61.11.1160.14","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-04-0269"},{"key":"2025121403104389000_61.11.1160.15","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1209178"},{"key":"2025121403104389000_61.11.1160.16","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-06-028969"},{"key":"2025121403104389000_61.11.1160.17","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-10-055145"},{"key":"2025121403104389000_61.11.1160.18","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2006.09.4474"},{"key":"2025121403104389000_61.11.1160.19","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(05)70213-8"},{"key":"2025121403104389000_61.11.1160.20","doi-asserted-by":"publisher","DOI":"10.1172\/JCI26833"},{"key":"2025121403104389000_61.11.1160.21","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.10767"},{"key":"2025121403104389000_61.11.1160.22","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-07-1708"},{"key":"2025121403104389000_61.11.1160.23","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1704367"},{"key":"2025121403104389000_61.11.1160.24","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-002-0556-2"},{"key":"2025121403104389000_61.11.1160.25","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2004.04.016"},{"key":"2025121403104389000_61.11.1160.26","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-09-3080"},{"key":"2025121403104389000_61.11.1160.27","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.03.6327"},{"key":"2025121403104389000_61.11.1160.28","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdi037"},{"key":"2025121403104389000_61.11.1160.29","doi-asserted-by":"publisher","DOI":"10.1023\/A:1008200307625"},{"key":"2025121403104389000_61.11.1160.30","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-9896(199712)183:4<432::AID-PATH942>3.0.CO;2-4"},{"key":"2025121403104389000_61.11.1160.31","doi-asserted-by":"publisher","DOI":"10.1016\/0046-8177(90)90148-X"},{"key":"2025121403104389000_61.11.1160.32","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1093\/ajcp\/91.2.152","article-title":"Immunohistochemical analysis of peripheral T-cell lymphoma in Japanese patients.","volume":"91","author":"Doi","year":"1989","journal-title":"Am J Clin Pathol"},{"key":"2025121403104389000_61.11.1160.33","first-page":"549","article-title":"Clonal gene rearrangement patterns correlate with immunophenotype and clinical parameters in patients with angioimmunoblastic lymphadenopathy.","volume":"133","author":"Feller","year":"1988","journal-title":"Am J Pathol"},{"key":"2025121403104389000_61.11.1160.34","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1182\/blood.V72.2.413.413","article-title":"Characteristic karyotypic pattern in T-cell lymphoproliferative disorders with reactive \u201cangioimmunoblastic lymphadenopathy with dysproteinemia-type\u201d features.","volume":"72","author":"Kaneko","year":"1988","journal-title":"Blood"},{"key":"2025121403104389000_61.11.1160.35","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1365-2141.1987.tb02290.x","article-title":"Diagnostic and prognostic value of monoclonal antibodies in immunophenotyping of angioimmunoblastic lymphadenopathy\/lymphogranulomatosis X.","volume":"67","author":"Knecht","year":"1987","journal-title":"Br J Haematol"},{"key":"2025121403104389000_61.11.1160.36","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19911215)68:12<2566::AID-CNCR2820681206>3.0.CO;2-Z"},{"key":"2025121403104389000_61.11.1160.37","first-page":"279","article-title":"Phenotyping of proliferating lymphocytes in angioimmunoblastic lymphadenopathy and related lesions by the double immunoenzymatic staining technique.","volume":"127","author":"Namikawa","year":"1987","journal-title":"Am J Pathol"},{"key":"2025121403104389000_61.11.1160.38","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19920901)70:3+<1259::AID-CNCR2820701511>3.0.CO;2-D"},{"key":"2025121403104389000_61.11.1160.39","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/BF00193945","article-title":"Genetic changes in atypical hyperplasia and lymphoma with angioimmunoblastic lymphadenopathy and dysproteinaemia in the same patients.","volume":"425","author":"Ohshima","year":"1994","journal-title":"Virchows Arch"},{"key":"2025121403104389000_61.11.1160.40","doi-asserted-by":"publisher","DOI":"10.1097\/00000478-199806000-00001"},{"key":"2025121403104389000_61.11.1160.41","first-page":"1093","article-title":"Epstein\u2013Barr virus in a CD8-positive T cell lymphoma.","volume":"136","author":"Richel","year":"1990","journal-title":"Am J Pathol"},{"key":"2025121403104389000_61.11.1160.42","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19920515)69:10<2571::AID-CNCR2820691030>3.0.CO;2-S"},{"key":"2025121403104389000_61.11.1160.43","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1182\/blood.V72.3.1000.bloodjournal7231000","article-title":"Clinicopathologic, immunophenotypic, and immunogenotypic analyses of immunoblastic lymphadenopathy-like T-cell lymphoma.","volume":"72","author":"Tobinai","year":"1988","journal-title":"Blood"},{"key":"2025121403104389000_61.11.1160.44","first-page":"392","article-title":"Clonal T cell populations in angioimmunoblastic lymphadenopathy and angioimmunoblastic lymphadenopathy-like lymphoma.","volume":"122","author":"Weiss","year":"1986","journal-title":"Am J Pathol"},{"key":"2025121403104389000_61.11.1160.45","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.10758"},{"key":"2025121403104389000_61.11.1160.46","doi-asserted-by":"publisher","DOI":"10.1007\/s004280050459"},{"key":"2025121403104389000_61.11.1160.47","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1007\/BF02982089","article-title":"CD3+CD4\u2212CD8\u2212TCR\u2212alphabeta+ T-cell lymphoma with clinical features of primary effusion lymphoma: an autopsy case.","volume":"74","author":"Yamamoto","year":"2001","journal-title":"Int J Hematol"},{"key":"2025121403104389000_61.11.1160.48","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-07-1960"},{"key":"2025121403104389000_61.11.1160.49","doi-asserted-by":"crossref","first-page":"4480","DOI":"10.4049\/jimmunol.136.12.4480","article-title":"The relationship of CD16 (Leu-11) and Leu-19 (NKH-1) antigen expression on human peripheral blood NK cells and cytotoxic T lymphocytes.","volume":"136","author":"Lanier","year":"1986","journal-title":"J Immunol"},{"key":"2025121403104389000_61.11.1160.50","unstructured":"Knowles DM . Immunohistochemical markers useful in the diagnosis and classification of hematopoietic neoplasms. In: Knowles D M , ed. Neoplastic hematopathology. 2nd edn. Philadelphia: Lippincott Williams & Wilkins, 2001:93\u2013226."},{"key":"2025121403104389000_61.11.1160.51","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.3880133"},{"key":"2025121403104389000_61.11.1160.52","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1093\/ajcp\/102.4.483","article-title":"CD20+ T-cell lymphoma. Neoplastic transformation of a normal T-cell subset.","volume":"102","author":"Quintanilla-Martinez","year":"1994","journal-title":"Am J Clin Pathol"},{"key":"2025121403104389000_61.11.1160.53","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.3880265"},{"key":"2025121403104389000_61.11.1160.54","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1097\/00000478-200312000-00003","article-title":"Peripheral T-cell lymphomas expressing CD30 and CD15.","volume":"27","author":"Barry","year":"2003","journal-title":"Am J Surg Pathol"},{"key":"2025121403104389000_61.11.1160.55","first-page":"319","article-title":"CD30-positive T-cell lymphomas co-expressing CD15: an immunohistochemical analysis.","volume":"22","author":"Gorczyca","year":"2003","journal-title":"Int J Oncol"},{"key":"2025121403104389000_61.11.1160.56","doi-asserted-by":"publisher","DOI":"10.1309\/YCH8-DWUF-FQBK-GPVB"},{"key":"2025121403104389000_61.11.1160.57","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.3800778"},{"key":"2025121403104389000_61.11.1160.58","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-04-017632"},{"key":"2025121403104389000_61.11.1160.59","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-05-0146"},{"key":"2025121403104389000_61.11.1160.60","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-11-3574"},{"key":"2025121403104389000_61.11.1160.61","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-4608(01)00386-7"},{"key":"2025121403104389000_61.11.1160.62","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.jbchem.a022003"},{"key":"2025121403104389000_61.11.1160.63","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)63463-3"},{"key":"2025121403104389000_61.11.1160.64","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1206034"},{"key":"2025121403104389000_61.11.1160.65","doi-asserted-by":"publisher","DOI":"10.1038\/ncb1093"},{"key":"2025121403104389000_61.11.1160.66","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M011682200"},{"key":"2025121403104389000_61.11.1160.67","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1207091"},{"key":"2025121403104389000_61.11.1160.68","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M008955200"},{"key":"2025121403104389000_61.11.1160.69","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1206115"},{"key":"2025121403104389000_61.11.1160.70","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1205540"},{"key":"2025121403104389000_61.11.1160.71","doi-asserted-by":"publisher","DOI":"10.1093\/intimm\/dxh112"},{"key":"2025121403104389000_61.11.1160.72","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.175.12.7837"},{"key":"2025121403104389000_61.11.1160.73","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.173.1.68"},{"key":"2025121403104389000_61.11.1160.74","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2003-4-10-r70"},{"key":"2025121403104389000_61.11.1160.75","doi-asserted-by":"crossref","first-page":"3408","DOI":"10.1046\/j.1432-1033.2003.03723.x","article-title":"Regulation of Cyr61\/CCN1 gene expression through RhoA GTPase and p38MAPK signaling pathways.","volume":"270","author":"Han","year":"2003","journal-title":"Eur J Biochem"},{"key":"2025121403104389000_61.11.1160.76","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M305862200"},{"key":"2025121403104389000_61.11.1160.77","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M301534200"},{"key":"2025121403104389000_61.11.1160.78","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1205682"},{"key":"2025121403104389000_61.11.1160.79","first-page":"5603","article-title":"Expression and function of CYR61, an angiogenic factor, in breast cancer cell lines and tumor biopsies.","volume":"60","author":"Tsai","year":"2000","journal-title":"Cancer Res"},{"key":"2025121403104389000_61.11.1160.80","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M402305200"},{"key":"2025121403104389000_61.11.1160.81","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.10631"},{"key":"2025121403104389000_61.11.1160.82","doi-asserted-by":"publisher","DOI":"10.1210\/me.2004-0215"},{"key":"2025121403104389000_61.11.1160.83","doi-asserted-by":"publisher","DOI":"10.1002\/hon.786"},{"key":"2025121403104389000_61.11.1160.84","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-01-134270"},{"key":"2025121403104389000_61.11.1160.85","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V99.2.627"},{"key":"2025121403104389000_61.11.1160.86","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1097\/00000478-200401000-00005","article-title":"CD10 expression in extranodal dissemination of angioimmunoblastic T-cell lymphoma.","volume":"28","author":"Attygalle","year":"2004","journal-title":"Am J Surg Pathol"},{"key":"2025121403104389000_61.11.1160.87","doi-asserted-by":"publisher","DOI":"10.1097\/00000478-200604000-00009"},{"key":"2025121403104389000_61.11.1160.88","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1038\/modpathol.3800625","article-title":"Expression of CXCL13, a chemokine highly upregulated in germinal center T-helper cells, distinguishes angioimmunoblastic T-cell lymphoma from peripheral T-cell lymphoma, unspecified.","volume":"19","author":"Grogg","year":"2006","journal-title":"Mod Pathol"},{"key":"2025121403104389000_61.11.1160.89","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.10864"},{"key":"2025121403104389000_61.11.1160.90","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19930801)72:3<909::AID-CNCR2820720341>3.0.CO;2-O"},{"key":"2025121403104389000_61.11.1160.91","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2559.2001.01058.x"},{"key":"2025121403104389000_61.11.1160.92","first-page":"337","article-title":"Quantitative analysis of cellular proliferative activity in 35 T-cell non-Hodgkin\u2019s lymphomas. Use of proliferating cell nuclear antigen and Ki-67 (MIB-1) antibodies and nucleolar organizer regions.","volume":"18","author":"Caulet-Maugendre","year":"1996","journal-title":"Anal Quant Cytol Histol"},{"key":"2025121403104389000_61.11.1160.93","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1182\/blood.V83.6.1460.1460","article-title":"Prognostic significance of the Ki-67-associated proliferative antigen in aggressive non-Hodgkin\u2019s lymphomas: a prospective Southwest Oncology Group trial.","volume":"83","author":"Miller","year":"1994","journal-title":"Blood"},{"key":"2025121403104389000_61.11.1160.94","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2184.1997.00066.x"},{"key":"2025121403104389000_61.11.1160.95","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/j.1365-2559.1993.tb00128.x","article-title":"Peripheral T-cell lymphoma: a clinicopathological study of 41 cases and evaluation of the prognostic significance of the updated Kiel classification.","volume":"22","author":"Montalban","year":"1993","journal-title":"Histopathology"},{"key":"2025121403104389000_61.11.1160.96","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.20341"},{"key":"2025121403104389000_61.11.1160.97","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-02-075036"},{"key":"2025121403104389000_61.11.1160.98","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2403960"},{"key":"2025121403104389000_61.11.1160.99","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-07-1148"},{"key":"2025121403104389000_61.11.1160.100","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-06-1275"},{"key":"2025121403104389000_61.11.1160.101","doi-asserted-by":"publisher","DOI":"10.1080\/10428190601016167"},{"key":"2025121403104389000_61.11.1160.102","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1182\/blood.V82.3.807.807","article-title":"Effect of Campath-1H antibody on human hematopoietic progenitors in vitro.","volume":"82","author":"Gilleece","year":"1993","journal-title":"Blood"},{"key":"2025121403104389000_61.11.1160.103","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1016\/S0140-6736(88)90588-0","article-title":"Remission induction in non-Hodgkin lymphoma with reshaped human monoclonal antibody CAMPATH-1H.","volume":"2","author":"Hale","year":"1988","journal-title":"Lancet"},{"key":"2025121403104389000_61.11.1160.104","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1089\/scd.1.1994.3.15","article-title":"CAMPATH-1 monoclonal antibodies in bone marrow transplantation.","volume":"3","author":"Hale","year":"1994","journal-title":"J Hematother"},{"key":"2025121403104389000_61.11.1160.105","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V99.10.3554"},{"key":"2025121403104389000_61.11.1160.106","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2002.06.119"},{"key":"2025121403104389000_61.11.1160.107","doi-asserted-by":"publisher","DOI":"10.1053\/j.seminoncol.2006.01.029"},{"key":"2025121403104389000_61.11.1160.108","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-10-3389"},{"key":"2025121403104389000_61.11.1160.109","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-02-074641"},{"key":"2025121403104389000_61.11.1160.110","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2004.03.050"},{"key":"2025121403104389000_61.11.1160.111","doi-asserted-by":"publisher","DOI":"10.1517\/13543784.16.7.1111"},{"key":"2025121403104389000_61.11.1160.112","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-09-008086"},{"key":"2025121403104389000_61.11.1160.113","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdm579"}],"container-title":["Journal of Clinical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jcp.2008.055335","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,14]],"date-time":"2025-12-14T11:10:57Z","timestamp":1765710657000},"score":1,"resource":{"primary":{"URL":"https:\/\/jcp.bmj.com\/lookup\/doi\/10.1136\/jcp.2008.055335"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,8,28]]},"references-count":113,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2008,10,27]]},"published-print":{"date-parts":[[2008,11]]}},"alternative-id":["10.1136\/jcp.2008.055335"],"URL":"https:\/\/doi.org\/10.1136\/jcp.2008.055335","relation":{},"ISSN":["0021-9746","1472-4146"],"issn-type":[{"value":"0021-9746","type":"print"},{"value":"1472-4146","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,8,28]]}}}